Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | September 2009 |
| End Date: | September 2009 |
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions
The objective of this study was to prove the bioequivalence of Roxane Laboratories'
Tinidazole 500 mg Tablet under fed conditions.
Tinidazole 500 mg Tablet under fed conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to tinidazole or any comparable or similar
product.
We found this trial at
1
site
Click here to add this to my saved trials
